June 10, 2025 Understanding Accounting and Bookkeeping Services for Business Success
May 27, 2025 How much does a Turkish passport cost?
May 22, 2025 How Measurement and Mix Modeling Drive Better Business Decisions
May 22, 2025 Are you making these mistakes when analyzing candlestick patterns?
April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency
Allogene Therapeutics (ALLO) Stock Forecast for 2025, 2026, 2027. Sell or Buy?
Updated: June 22, 2025 (19:31)
Sector: HealthcareThe share price of Allogene Therapeutics, Inc. (ALLO) now
Are you interested in Allogene Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Allogene Therapeutics stock price in 2025, 2026, 2027. How much will one Allogene Therapeutics share be worth in 2025 - 2027?
When should I take profit in Allogene Therapeutics stock? When should I record a loss on Allogene Therapeutics stock? What are analysts' forecasts for Allogene Therapeutics stock? What is the future of Allogene Therapeutics stock? We forecast Allogene Therapeutics stock performance using neural networks based on historical data on Allogene Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Allogene Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Allogene Therapeutics shares. This happens once a day.
Historical and forecast chart of Allogene Therapeutics stock
The chart below shows the historical price of Allogene Therapeutics stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Allogene Therapeutics stock price can be found in the table below.
Long-term forecasts by years.
Allogene Therapeutics, Inc. operates as a biotechnology company. The Company develops allogeneic chimeric antigen receptor T-cell therapy for the treatment of blood cancers and solid tumors. Allogene Therapeutics serves patients in the State of California.
Allogene Therapeutics daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jun 24 | 1.16 | 1.11 | 1.22 | 9.85 |
| Jun 25 | 1.19 | 1.15 | 1.25 | 8.58 |
| Jun 26 | 1.12 | 1.06 | 1.17 | 10.75 |
| Jun 27 | 1.12 | 1.08 | 1.15 | 6.63 |
| Jun 28 | 1.16 | 1.10 | 1.19 | 8.03 |
| Jun 29 | 1.12 | 1.06 | 1.17 | 9.60 |
| Jun 30 | 1.12 | 1.09 | 1.17 | 7.07 |
| Jul 01 | 1.08 | 1.03 | 1.10 | 7.09 |
| Jul 02 | 1.07 | 1.06 | 1.13 | 7.11 |
| Jul 03 | 1.04 | 0.98 | 1.07 | 8.89 |
| Jul 04 | 1.00 | 0.97 | 1.03 | 6.32 |
| Jul 05 | 0.97 | 0.95 | 1.00 | 5.66 |
| Jul 06 | 1.03 | 0.99 | 1.08 | 9.12 |
| Jul 07 | 1.06 | 1.01 | 1.10 | 8.93 |
| Jul 08 | 1.10 | 1.05 | 1.15 | 8.87 |
| Jul 09 | 1.06 | 1.03 | 1.11 | 7.87 |
| Jul 10 | 1.10 | 1.07 | 1.15 | 7.26 |
| Jul 11 | 1.11 | 1.05 | 1.16 | 9.99 |
| Jul 12 | 1.05 | 1.02 | 1.10 | 7.40 |
| Jul 13 | 1.00 | 0.98 | 1.02 | 3.94 |
| Jul 14 | 1.00 | 0.96 | 1.02 | 6.03 |
| Jul 15 | 0.95 | 0.91 | 0.97 | 6.77 |
| Jul 16 | 0.98 | 0.97 | 1.04 | 6.82 |
| Jul 17 | 1.01 | 0.98 | 1.07 | 8.49 |
| Jul 18 | 0.98 | 0.96 | 1.02 | 6.11 |
| Jul 19 | 1.00 | 0.98 | 1.06 | 8.07 |
| Jul 20 | 0.96 | 0.91 | 0.99 | 9.63 |
| Jul 21 | 0.93 | 0.89 | 0.96 | 7.92 |
| Jul 22 | 0.92 | 0.91 | 0.94 | 2.98 |
| Jul 23 | 0.88 | 0.84 | 0.93 | 10.96 |
Allogene Therapeutics Daily Price Targets
Allogene Therapeutics Stock Forecast 06-24-2025.
Forecast target price for 06-24-2025: $1.16.
Negative dynamics for Allogene Therapeutics shares will prevail with possible volatility of 8.966%.
Pessimistic target level: 1.11
Optimistic target level: 1.22
Allogene Therapeutics Stock Forecast 06-25-2025.
Forecast target price for 06-25-2025: $1.19.
Positive dynamics for Allogene Therapeutics shares will prevail with possible volatility of 7.898%.
Pessimistic target level: 1.15
Optimistic target level: 1.25
Allogene Therapeutics Stock Forecast 06-26-2025.
Forecast target price for 06-26-2025: $1.12.
Negative dynamics for Allogene Therapeutics shares will prevail with possible volatility of 9.708%.
Pessimistic target level: 1.06
Optimistic target level: 1.17
Allogene Therapeutics Stock Forecast 06-27-2025.
Forecast target price for 06-27-2025: $1.12.
Positive dynamics for Allogene Therapeutics shares will prevail with possible volatility of 6.221%.
Pessimistic target level: 1.08
Optimistic target level: 1.15
Allogene Therapeutics Stock Forecast 06-28-2025.
Forecast target price for 06-28-2025: $1.16.
Positive dynamics for Allogene Therapeutics shares will prevail with possible volatility of 7.433%.
Pessimistic target level: 1.10
Optimistic target level: 1.19
Allogene Therapeutics Stock Forecast 06-29-2025.
Forecast target price for 06-29-2025: $1.12.
Negative dynamics for Allogene Therapeutics shares will prevail with possible volatility of 8.756%.
Pessimistic target level: 1.06
Optimistic target level: 1.17
ALLO (ALLO) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jul. | 1.21 | 1.17 | 1.25 | 6.36 |
| Jul. | 1.24 | 1.19 | 1.32 | 10.21 |
| Aug. | 1.19 | 1.13 | 1.25 | 9.76 |
| Oct. | 1.07 | 1.02 | 1.14 | 10.56 |
| Oct. | 1.12 | 1.06 | 1.20 | 11.69 |
| Dec. | 1.11 | 1.04 | 1.14 | 9.40 |
| Dec. | 1.19 | 1.12 | 1.27 | 11.54 |
Allogene Therapeutics forecast for this year
Allogene Therapeutics Stock Prediction for Jul 2025
An downtrend is forecast for this month with an optimal target price of $1.20627. Pessimistic: $1.17. Optimistic: $1.25
Allogene Therapeutics Stock Prediction for Jul 2025
An uptrend is forecast for this month with an optimal target price of $1.24005. Pessimistic: $1.19. Optimistic: $1.32
Allogene Therapeutics Stock Prediction for Aug 2025
An downtrend is forecast for this month with an optimal target price of $1.18672. Pessimistic: $1.13. Optimistic: $1.25
Allogene Therapeutics Stock Prediction for Oct 2025
An downtrend is forecast for this month with an optimal target price of $1.07161. Pessimistic: $1.02. Optimistic: $1.14
Allogene Therapeutics Stock Prediction for Oct 2025
An uptrend is forecast for this month with an optimal target price of $1.12412. Pessimistic: $1.06. Optimistic: $1.20
Allogene Therapeutics Stock Prediction for Dec 2025
An downtrend is forecast for this month with an optimal target price of $1.10838. Pessimistic: $1.04. Optimistic: $1.14
Allogene Therapeutics Stock Prediction for Dec 2025
An uptrend is forecast for this month with an optimal target price of $1.18929. Pessimistic: $1.12. Optimistic: $1.27
Allogene Therapeutics (ALLO) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 1.20 | 1.13 | 1.24 | 8.86 |
| Mar | 1.18 | 1.15 | 1.26 | 8.64 |
| Mar | 1.13 | 1.10 | 1.17 | 5.62 |
| May | 1.10 | 1.06 | 1.15 | 7.21 |
| May | 1.12 | 1.06 | 1.18 | 9.71 |
| Jul | 1.23 | 1.16 | 1.33 | 12.91 |
| Jul | 1.36 | 1.30 | 1.45 | 10.10 |
| Aug | 1.30 | 1.25 | 1.35 | 7.31 |
| Oct | 1.39 | 1.34 | 1.44 | 7.07 |
| Oct | 1.47 | 1.41 | 1.55 | 9.29 |
| Dec | 1.55 | 1.46 | 1.63 | 10.55 |
| Dec | 1.70 | 1.66 | 1.73 | 4.40 |
Allogene Therapeutics (ALLO) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 1.56 | 1.48 | 1.66 | 10.63 |
| Mar | 1.41 | 1.35 | 1.48 | 8.60 |
| Mar | 1.44 | 1.35 | 1.54 | 12.50 |
| May | 1.37 | 1.29 | 1.41 | 9.02 |
| May | 1.34 | 1.29 | 1.40 | 7.86 |
| Jul | 1.28 | 1.20 | 1.35 | 11.62 |
| Jul | 1.26 | 1.19 | 1.34 | 10.86 |
| Aug | 1.39 | 1.31 | 1.46 | 10.42 |
| Oct | 1.42 | 1.31 | 1.52 | 13.62 |
| Oct | 1.47 | 1.38 | 1.55 | 10.98 |
| Dec | 1.45 | 1.41 | 1.49 | 5.25 |
| Dec | 1.37 | 1.31 | 1.41 | 6.80 |
Allogene Therapeutics information and performance
210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, US
Market capitalization of the Allogene Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ALLO shares in the company outstanding by the market price of one share.
EBITDA of Allogene Therapeutics is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
FAQ (Frequently Asked Questions about Allogene Therapeutics Stock)
Should I Buy Allogene Therapeutics Shares in 2025 year?
Does Allogene Therapeutics pay dividends?
Which economic sector do Allogene Therapeutics's shares belong to?
Which other securities belong to the same sector as Allogene Therapeutics's shares?
